Phase II Study of AP0302 5% Versus a Vehicle Comparator

Conditions

• Pain
• Delayed Onset Muscle Soreness

Interventions

• DRUG: S-Ibuprofen Topical Gel 5%
• DRUG: Vehicle Topical Gel

Sponsor

Aponia Laboratories, Inc.